Drug Shortage Report for JAMP-METHOTREXATE

Last updated on 2020-10-09 History
Report ID 4836
Drug Identification Number 02419173
Brand name JAMP-METHOTREXATE
Common or Proper name Methotrexate Solution
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) METHOTREXATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS
Packaging size 5x2
ATC code L01BA
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-09-15
Estimated end date
Actual end date 2020-09-04
Shortage status Resolved
Updated date 2020-10-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-10-09 French Compare
v14 2020-10-09 English Compare
v13 2020-02-18 French Compare
v12 2020-02-18 English Compare
v11 2019-03-01 French Compare
v10 2019-03-01 English Compare
v9 2018-12-19 French Compare
v8 2018-12-19 English Compare
v7 2018-10-15 French Compare
v6 2018-10-15 English Compare
v5 2017-09-25 French Compare
v4 2017-09-25 English Compare
v3 2017-09-25 English Compare
v2 2017-03-30 French Compare
v1 2017-03-30 English Compare

Showing 1 to 15 of 15